Company / Revenue
IONIS PHARMACEUTICALS INC Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$943.7M
FY2025
5-year range
$151.9M / $943.7M
FY2021-FY2025
Trend
+316.5%
vs FY2024
Sector context
#43 of 155
Health Care
What the data says
Revenue changed +317% YoY in FY2025, a notable deviation from the 9-year average annual change of +61%.
Based on SEC 10-K filings.
$944M in FY2025 with a 5-year CAGR of +26.6%.
Improved from $325M to $944M over the past 2 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- +83.8%
- 5-Year CAGR
- +26.6%
- 10-Year CAGR
- -
Sector benchmark
#43 of 155 in Health CareTop 28% of 155This company $943.7M Sector average $4.5B
▼
-78.9% below sector average
Key checks
Key Insights
- 5-year CAGR of +26.6%, indicating consistent growth.
- In FY2025, revenue increased 316.5% year-over-year.
- Ranks #43 out of 155 companies in the Health Care sector.
- Lowest revenue in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -0.18 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $943.7M | +316.5% |
| FY2024 | $226.6M | -30.2% |
| FY2023 | $324.5M | +113.6% |
| FY2022 | $151.9M | -65.5% |
| FY2021 | $440.0M | +51.6% |
| FY2020 | $290.3M | -41.2% |
| FY2019 | $493.7M | +241.8% |
| FY2018 | $144.4M | +30.9% |
| FY2017 | $110.3M | -68.2% |
| FY2016 | $346.6M | +22.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026